{"symbol":"AMGN","fiscalQuarter":"Q4-2016","reportDate":"2017-02-02","reportTime":"AMC","status":"reported","company":{"name":"Amgen Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2016","postBrief":{"headline":"Amgen Beats on EPS, Stock Down 0.06%","keyNumbers":[{"metric":"EPS","actual":"$2.89","expected":"N/A","surprise":"+4.26%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on delivering value to our shareholders."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, no specific guidance was provided for future performance."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock experienced a slight decline of 0.06%, suggesting that investors may have been looking for more comprehensive guidance or additional insights into future performance. The lack of revenue data and guidance may have contributed to the muted stock reaction.","metaDescription":"Amgen Inc (AMGN) Q4 2016 earnings: EPS beat by 4.26%. Stock down 0.06%. Full breakdown."}}